Increased Frequency of CD4+ CD25+ FoxP3+ T Regulatory Cells in Pulmonary Tuberculosis Patients Undergoing Specific Treatment and Its Relationship with Their Immune-Endocrine Profile

Abstract EN

Tuberculosis (TB) is a major health problem requiring an appropriate cell immune response (IR) to be controlled.

Since regulatory T cells (Tregs) are relevant in IR regulation, we analyzed Tregs variations throughout the course of TB treatment and its relationship with changes in immune-endocrine mediators dealing with disease immunopathology.

The cohort was composed of 41 adult patients, 20 of them completing treatment and follow-up.

Patients were bled at diagnosis (T0) and at 2 (T2), 4 (T4), 6 (T6), and 9 months following treatment initiation.

Twenty-four age- and sex-matched healthy controls (HCo) were also included.

Tregs (flow cytometry) from TB patients were increased at T0 (versus HCo P<0.05), showing even higher values at T2 (versus T0 P<0.01) and T4 (versus T0 P<0.001).

While IL-6, IFN-γ, TGF-β (ELISA), and Cortisol (electrochemiluminescence, EQ) were augmented, DHEA-S (EQ) levels were diminished at T0 with respect to HCo, with cytokines and Cortisol returning to normal values at T9.

Tregs correlated positively with IFN-γ (R=0.868, P<0.05) at T2 and negatively at T4 (R=-0.795, P<0.05).

Lowered levels of proinflammatory cytokines together with an increased frequency of Tregs of patients undergoing specific treatment might reflect a downmodulatory effect of these cells on the accompanying inflammation.